Chasing biotech, state by state - Winners and losers

Nature Biotechnology

Volumn 23, Issue 2, 2005, Pages 175-179

  Wilan, Ken Howard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ECONOMIC AND SOCIAL EFFECTS; PROBLEM SOLVING; SOCIAL ASPECTS;

ECONOMIC PROSPERITY; OBSTACLES;

BIOTECHNOLOGY;

BIOTECHNOLOGICAL PRODUCTION; CAPITAL; DRUG APPROVAL; ECONOMIC DEVELOPMENT; EMPLOYMENT; INCOME; INVESTMENT; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW;

BIOTECHNOLOGY; ENTREPRENEURSHIP; FINANCING, GOVERNMENT; GOVERNMENT PROGRAMS; INVESTMENTS; OWNERSHIP; UNITED STATES;

EID: 13844275532     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0205-175     Document Type: Review

References (5)

1. A survey of the use of biotechnology in US industry (US Department of Commerce, Technology Administration, Bureau of Industry and Security, Washington, DC, 2003).
2. Resurgence: the Americas perspective. Global biotechnology report (Ernst & Young, New York, 2004).
3. Beyond borders: global biotechnology report (Ernst & Young, New York, 2002).
4. MoneyTree Survey: Investments by industry/Q2 2004 (PricewaterhouseCoopers, New York; Thomson Venture Economics, New York; and the National Venture Capital Association, Arlington, VA, 2004).
5. Cortright, J. & Mayer, H. Signs of life: the growth of biotechnology centers in the US. (Brookings Institution Center on Urban and Metropolitan Policy, Washington, DC, 2002).